GSK joins a crowd of pharma companies restricting sales under federal program – Endpoints News
GlaxoSmithKline recently became the 14th biopharma company to switch up its approach to distributing drugs purchased via the federal 340B program for low-income individuals. Effective April 1, GSK said it […]